Dec 16, 2020, 14:12 PM by

Student placement to provide invaluable commercial insight and hands-on experience. The educational programme now in its fifth year

Dec 16, 2020, 14:12 PM by

Resolve Biosciences today announced the completion of a $24 million Series A financing round and the appointment of Co-founder Jason T. Gammack as CEO

Dec 16, 2020, 14:12 PM by

Scottish kidney specialist named winner at Scottish Health Awards for crucial work during coronavirus outbreak.

Dec 16, 2020, 14:11 PM by

Dec 16, 2020, 14:11 PM by

Dec 16, 2020, 14:11 PM by

Dec 16, 2020, 14:11 PM by

Dec 16, 2020, 14:11 PM by

Dec 16, 2020, 14:10 PM by

London, UK. 14th December 2020: Page & Page and Partners, the global creative communications agency specialising in health, wellness, and lifestyle, is today announcing the appointment of two new full-time staff. The new joiners are: Kirstie Turner – Writer and editor and Georgie Epps – Mid weight creative.

Dec 16, 2020, 14:10 PM by

Dec 16, 2020, 14:10 PM by

IntelyCare reports record growth in 2020 amid surging demand for data science-driven staffing technology in the post-acute market.

Dec 16, 2020, 14:10 PM by

Qlucore, leading software provider of powerful visualization-based bioinformatics data analysis tools for research and precision diagnostics, is working with leading scientific experts at Lund University (Sweden), Gothenburg University (Sweden) and in China to develop new diagnostics methods and software solutions to significantly improve disease stratification and treatment selection of patients diagnosed with cancer.

Dec 16, 2020, 14:10 PM by

Dec 16, 2020, 14:10 PM by

Dec 16, 2020, 14:10 PM by

Dec 16, 2020, 14:10 PM by

Dec 16, 2020, 14:10 PM by

iVexSol, a Worcester, MA-based manufacturer of lentiviral vector (LVV), announced a $13.0M Series A funding round. LVV is a critical raw material in the development of important new cell and gene therapies. iVexSol’s technology can reliably produce LVV at significantly greater quantities than traditional processes, enabling a smaller manufacturing footprint, and facilitating the rapid scale-out needed for global demand. The funding will be used to establish a cGMP manufacturing facility in Lexington, MA.

Dec 16, 2020, 14:10 PM by

Optibrium, Intellegens and Medicines Discovery Catapult combine their expertise in drug discovery and AI research

Dec 16, 2020, 14:10 PM by

• Start-up to leverage gamification and cognitive rehabilitation targeting cognition, mood and behaviors in patients with mild-to-moderate Alzheimer’s disease • Digital therapeutics solution collects digital biomarkers via computer tablets in the home to assess and monitor cognitive function, thereby delivering personalized cognitive intervention • Can be prescribed as a stand-alone therapeutic or as combination therapy with a drug

Dec 16, 2020, 14:10 PM by